> All the big AIM fraud exposés
> 300 articles and podcasts a month
> Hot share tips
> Original investigations by our experienced team
> No ads, no click-bait, no auto-play videos
By Tom Winnifrith | Tuesday 8 January 2019If you like this, please share this article using the buttons below
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
If you are a shareholder in OptiBiotix, Sosandar, SkinBioTherapeutics, Yourgene, Concepta or Big Sofa then put 21st January in your diary now! That evening, the man who listed all those companies and who is still involved with or close to all, will be quizzed at the next UK Investor City Forum at PwC in the City of London. Places are limited to just 90 and are first come first served. You can book a free seat HERE.
Adam Reynolds is controversial and while Optibiotix is already more than a ten bagger, not all of his IPOs have flown. So what makes him tick? How does he select companies to list? And what are the prospects for every company in the stable? Adam promises to hold nothing back and will answer all questions asked on 21st January.
Adam is not the only attraction. There will also be presentations by Catenae Innovation, Red Emperor Resources and Hunters, a company in which Nigel Wray, aka Britain's Buffett, is invested. Find out what makes Nigel so sure this is a money spinner by coming along on 21st January.
Reynolds will be interviewed by Zak Mir but will also take questions from the audience in an extended session. To make sure you get your complimentary seat, which will be allocated on a first come first served basis, by booking a ticket today!
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen